Viewing Study NCT00458302


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2025-12-26 @ 2:22 AM
Study NCT ID: NCT00458302
Status: COMPLETED
Last Update Posted: 2012-12-19
First Post: 2007-04-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Sponsor: Janssen-Cilag International NV
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR013159
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators